Venture&Growth
Location
Dublin, Ireland 
Henry Zubaida
Investment Manager Healthtech
Venture&Growth
Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity College Dublin. The company is developing a novel treatment solution for patients with symptomatic BPH designed to be safely and effectively performed in a doctor’s office setting in a simple procedure under local anaesthesia. Gilde invested in 2022 to support the Company’s clinical programme and other operating activities in pursuit of regulatory approval for the ProVee system in Europe and the US.
More Proverum news
First Enrolment in the ProVIDE Clinical Study for BPH Treatment
Tagworks
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. The company is...
ADCendo
Danish Therapeutics company focused on antibody-drug conjugates (ADCs) for the treatment of cancers.
Purespring Therapeutics
Founded in 2020, Purespring is a pioneering London (UK)-based gene therapy company focused on transforming...
